← Leaderboards
Tong Wu
Tulane University Of Louisiana
$12,656,296
Attributed
$12,656,296
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,656,296 · 7
By mechanism
R01$12,430,546 · 6
R56$225,750 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorSignal TransductionPathway InteractionsChemopreventionMalignant NeoplasmsGrowthPreventInflammationPublic Health RelevanceIn VitroMolecularPublishingLaboratoriesMalignant - DescriptorCancer CellPlayProstaglandinsTissuesDinoprostoneCarcinogenesisIncidenceCellsPrimary Carcinoma Of The Liver CellsCell Growth
Grant awards (46)
Epigenetic Mechanisms of Biliary Epithelial Neoplasia$382,500
R01 · FY2025 · CA · contact PI
The Long Noncoding RNA MALAT1 in Liver Cancer$340,746
R01 · FY2023 · CA · contact PI
Epigenetic Mechanisms of Biliary Epithelial Neoplasia$267,688
R01 · FY2023 · CA · contact PI
The Long Noncoding RNA MALAT1 in Liver Cancer$340,746
R01 · FY2022 · CA · contact PI
Epigenetic Mechanisms of Biliary Epithelial Neoplasia$267,688
R01 · FY2022 · CA · contact PI
The Long Noncoding RNA MALAT1 in Liver Cancer$347,700
R01 · FY2021 · CA · contact PI
Epigenetic Mechanisms of Biliary Epithelial Neoplasia$61,928
R01 · FY2021 · CA · contact PI
Epigenetic Mechanisms of Biliary Epithelial Neoplasia$347,700
R01 · FY2020 · CA · contact PI
The Long Noncoding RNA MALAT1 in Liver Cancer$347,034
R01 · FY2020 · CA · contact PI
15-PGDH in Cholangiocarcinogenesis$344,269
R01 · FY2020 · CA · contact PI
The Long Noncoding RNA MALAT1 in Liver Cancer$345,222
R01 · FY2019 · CA · contact PI
Epigenetic Mechanisms of Biliary Epithelial Neoplasia$336,158
R01 · FY2019 · CA · contact PI
15-PGDH in Cholangiocarcinogenesis$333,940
R01 · FY2019 · CA · contact PI
15-PGDH in Cholangiocarcinogenesis$344,269
R01 · FY2018 · CA · contact PI
Epigenetic Mechanisms of Biliary Epithelial Neoplasia$344,269
R01 · FY2018 · CA · contact PI
15-PGDH in Cholangiocarcinogenesis$344,269
R01 · FY2017 · CA · contact PI
15-PGDH in Cholangiocarcinogenesis$344,269
R01 · FY2016 · CA · contact PI
TGF-beta, MALAT1 and 15-PGDH in Liver Cancer$225,750
R56 · FY2015 · DK · contact PI
Omega-3 Fatty Acids and Hepatic Carcinogenesis$284,744
R01 · FY2013 · CA · contact PI
Prostaglandin Signaling Pathway in Liver Cancer$224,012
R01 · FY2013 · CA · contact PI
cPLA2alpha and COX-2 in Cholangiocarcinoma$219,791
R01 · FY2013 · CA · contact PI
Omega-3 Fatty Acids and Hepatic Carcinogenesis$302,919
R01 · FY2012 · CA · contact PI
Prostaglandin Signaling Pathway in Liver Cancer$238,311
R01 · FY2012 · CA · contact PI
cPLA2alpha and COX-2 in Cholangiocarcinoma$233,820
R01 · FY2012 · CA · contact PI
cPLA2alpha, COX-2 and TGF-beta in Liver Cancer$313,448
R01 · FY2011 · DK · contact PI
Omega-3 Fatty Acids and Hepatic Carcinogenesis$302,919
R01 · FY2011 · CA · contact PI
Prostaglandin Signaling Pathway in Liver Cancer$238,311
R01 · FY2011 · CA · contact PI
cPLA2alpha and COX-2 in Cholangiocarcinoma$233,820
R01 · FY2011 · CA · contact PI
cPLA2alpha, COX-2 and TGF-beta in Liver Cancer$316,614
R01 · FY2010 · DK · contact PI
Omega-3 Fatty Acids and Hepatic Carcinogenesis$310,990
R01 · FY2010 · CA · contact PI
Prostaglandin Signaling Pathway in Liver Cancer$245,528
R01 · FY2010 · CA · contact PI
cPLA2alpha and COX-2 in Cholangiocarcinoma$240,251
R01 · FY2010 · CA · contact PI
Omega-3 Fatty Acids and Hepatic Carcinogenesis$314,363
R01 · FY2009 · CA · contact PI
Prostaglandin Signaling Pathway in Liver Cancer$247,365
R01 · FY2009 · CA · contact PI
cPLA2alpha and COX-2 in Cholangiocarcinoma$242,653
R01 · FY2009 · CA · contact PI
cPLA2alpha, COX-2 and TGF-beta in Liver Cancer$212,937
R01 · FY2009 · DK · contact PI
cPLA2alpha, COX-2 and TGF-beta in Liver Cancer$109,001
R01 · FY2009 · DK · contact PI
cPLA2alpha, COX-2 and TGF-beta in Liver Cancer$321,938
R01 · FY2008 · DK · contact PI
Prostaglandin Signaling Pathway in Liver Cancer$224,802
R01 · FY2008 · CA · contact PI
cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma$224,802
R01 · FY2008 · CA · contact PI
Prostaglandin Signaling Pathway in Liver Cancer$224,802
R01 · FY2007 · CA · contact PI
cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma$224,802
R01 · FY2007 · CA · contact PI
cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma$231,516
R01 · FY2006 · CA · contact PI
Prostaglandin Signaling Pathway in Liver Cancer$231,516
R01 · FY2006 · CA · contact PI
Prostaglandin Signaling Pathway in Liver Cancer$237,088
R01 · FY2005 · CA
cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma$237,088
R01 · FY2005 · CA